Literature DB >> 15777732

Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids.

Shagufta Ahmad1, Leslie J Fowler, Peter S Whitton.   

Abstract

We have studied the effects of treatment with the anticonvulsants lamotrigine (LTG), phenytoin (PHN) and carbamazepine (CBZ) on basal and stimulated extracellular aspartate (ASP), glutamate (GLU), taurine (TAU), GABA, 5-hydroxytryptamine (5-HT) and dopamine (DA) in the hippocampus of freely moving rats using microdialysis. All of the drugs investigated have had inhibition of Na(+) channel activity implicated as their principal mechanism of action. Neither LTG (10-20 mg/kg), PHN (20-40 mg/kg) or CBZ (10-20 mg/kg) had an effect on the basal extracellular concentrations of any of the amino acids studied with the exception of glutamate, which was decreased at the highest LTG dose. However, when amino acid transmitter levels were increased with 50 microM veratridine, LTG was found to cause a dose-dependent decrease in dialysate levels of all four amino acids, with the effect being most pronounced for glutamate. In contrast, PHN decreased extracellular aspartate levels but had no effect on evoked-extracellular GLU, TAU or GABA. Somewhat unexpectedly, CBZ did not alter the stimulated increase in the excitatory amino acids, GLU and ASP, but, rather surprisingly for an antiepileptic drug, markedly decreased that of the inhibitory substances TAU and GABA. The three drugs had differing effects on basal extracellular 5-HT and DA. LTG caused a dose-dependent decrease in both, while CBZ and PHN both increased extracellular 5-HT and DA. When extracellular 5-HT and DA was evoked by veratridine LTG had no significant effect on this, while PHN but not CBZ increased stimulated extracellular 5-HT and both PHN and CBZ augmented DA. Thus, the effects of the three drugs studied seemed to depend on whether extracellular transmitter levels are evoked or basal and the particular transmitter in question. This suggests that there are marked differences in the neurochemical mechanisms of antiepileptic drug action of the three compounds studied.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15777732     DOI: 10.1016/j.eplepsyres.2005.02.002

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  20 in total

1.  A double-blind, placebo-controlled trial of lamotrigine for pathological skin picking: treatment efficacy and neurocognitive predictors of response.

Authors:  Jon E Grant; Brian L Odlaug; Samuel R Chamberlain; Suck Won Kim
Journal:  J Clin Psychopharmacol       Date:  2010-08       Impact factor: 3.153

2.  The effect of lamotrigine on platelet serotonin concentration in patients with bipolar depression.

Authors:  Marina Sagud; Nela Pivac; Maja Mustapic; Gordana Nedic; Alma Mihaljevic Peles; Milivoj Kramaric; Miro Jakovljevic; Dorotea Muck-Seler
Journal:  Psychopharmacology (Berl)       Date:  2008-02-02       Impact factor: 4.530

Review 3.  Epileptic activity in Alzheimer's disease: causes and clinical relevance.

Authors:  Keith A Vossel; Maria C Tartaglia; Haakon B Nygaard; Adam Z Zeman; Bruce L Miller
Journal:  Lancet Neurol       Date:  2017-04       Impact factor: 44.182

4.  Effect of lamotrigine and carbamazepine on corticotropin-releasing factor-associated serotonergic transmission in rat dorsal raphe nucleus.

Authors:  Shunske Tanahashi; Satoshi Yamamura; Masanori Nakagawa; Eishi Motomura; Motohiro Okada
Journal:  Psychopharmacology (Berl)       Date:  2011-09-27       Impact factor: 4.530

5.  Effects of antiepileptic drugs on glutamate release from rat and human neocortical synaptosomes.

Authors:  M Kammerer; B Brawek; T M Freiman; R Jackisch; Thomas J Feuerstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-03-30       Impact factor: 3.000

6.  Regional differences in the effects of isoflurane on neurotransmitter release.

Authors:  Robert I Westphalen; No-Bong Kwak; Keir Daniels; Hugh C Hemmings
Journal:  Neuropharmacology       Date:  2011-05-30       Impact factor: 5.250

7.  Comorbidity between temporal lobe epilepsy and depression: a [18F]MPPF PET study.

Authors:  A Lothe; A Didelot; A Hammers; N Costes; M Saoud; F Gilliam; P Ryvlin
Journal:  Brain       Date:  2008-09-02       Impact factor: 13.501

Review 8.  Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy.

Authors:  Cecilie Johannessen Landmark
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

9.  Serotonin neurones have anti-convulsant effects and reduce seizure-induced mortality.

Authors:  Gordon F Buchanan; Nicholas M Murray; Michael A Hajek; George B Richerson
Journal:  J Physiol       Date:  2014-08-08       Impact factor: 5.182

10.  Modifications of antiepileptic drugs for improved tolerability and efficacy.

Authors:  Cecilie Johannessen Landmark; Svein I Johannessen
Journal:  Perspect Medicin Chem       Date:  2008-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.